Biotech · Private company
CAGE Bio Inc.
Track this companyFree. Adds CAGE Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- CGB-400Phase 2 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- CGB-500 Ointment with 1% tofacitinibPhase 2 · Atopic Dermatitis (AD)ClinicalTrials.gov · fetched Nov 12, 2026
- CGB-500 with 0.5% tofacitinibPhase 2 · Atopic Dermatitis (AD)ClinicalTrials.gov · fetched Nov 12, 2026
- Ruxolitinib 1.5% Cream QDPhase 2 · Atopic Dermatitis (AD)ClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle GelPhase 2 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- CGB-S-100Phase 1 · Bacterial OvergrowthClinicalTrials.gov · fetched Nov 12, 2026
- CB-0002BErythemaClinicalTrials.gov · fetched Nov 12, 2026
- CGB-400 Topical GelFungal InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic DermatitisPHASE2 · COMPLETED · started Apr 21, 2025ClinicalTrials.gov NCT06923228 · fetched Nov 12, 2026
- Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic DermatitisPHASE2 · COMPLETED · started Dec 18, 2024ClinicalTrials.gov NCT06810050 · fetched Nov 12, 2026
- An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal InfectionCOMPLETED · started Feb 8, 2022ClinicalTrials.gov NCT05202366 · fetched Nov 12, 2026
- CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of RosaceaPHASE2 · COMPLETED · started May 7, 2021ClinicalTrials.gov NCT04886739 · fetched Nov 12, 2026
- Clinical Evaluation of the Residual Antimicrobial ActivityEARLY_PHASE1 · COMPLETED · started Jun 16, 2020ClinicalTrials.gov NCT04495920 · fetched Nov 12, 2026
- CGB-400 for the Reduction of Facial Redness and Bumps and BlemishesPHASE1 · COMPLETED · started Oct 26, 2018ClinicalTrials.gov NCT04508205 · fetched Nov 12, 2026
- CGB-400 for the Reduction of Facial RednessPHASE1 · COMPLETED · started Oct 26, 2018ClinicalTrials.gov NCT04508660 · fetched Nov 12, 2026
- 50 Human Subject Repeat Insult Patch TestNA · COMPLETED · started Jan 18, 2017ClinicalTrials.gov NCT04498676 · fetched Nov 12, 2026